Correlation Between Oxford Nanopore and Crinetics Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Oxford Nanopore and Crinetics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oxford Nanopore and Crinetics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oxford Nanopore Technologies and Crinetics Pharmaceuticals, you can compare the effects of market volatilities on Oxford Nanopore and Crinetics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oxford Nanopore with a short position of Crinetics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oxford Nanopore and Crinetics Pharmaceuticals.
Diversification Opportunities for Oxford Nanopore and Crinetics Pharmaceuticals
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Oxford and Crinetics is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Oxford Nanopore Technologies and Crinetics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crinetics Pharmaceuticals and Oxford Nanopore is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oxford Nanopore Technologies are associated (or correlated) with Crinetics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crinetics Pharmaceuticals has no effect on the direction of Oxford Nanopore i.e., Oxford Nanopore and Crinetics Pharmaceuticals go up and down completely randomly.
Pair Corralation between Oxford Nanopore and Crinetics Pharmaceuticals
Assuming the 90 days horizon Oxford Nanopore Technologies is expected to generate 1.53 times more return on investment than Crinetics Pharmaceuticals. However, Oxford Nanopore is 1.53 times more volatile than Crinetics Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Crinetics Pharmaceuticals is currently generating about -0.21 per unit of risk. If you would invest 160.00 in Oxford Nanopore Technologies on October 26, 2024 and sell it today you would earn a total of 22.00 from holding Oxford Nanopore Technologies or generate 13.75% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 97.5% |
| Values | Daily Returns |
Oxford Nanopore Technologies vs. Crinetics Pharmaceuticals
Performance |
| Timeline |
| Oxford Nanopore Tech |
| Crinetics Pharmaceuticals |
Oxford Nanopore and Crinetics Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oxford Nanopore and Crinetics Pharmaceuticals
The main advantage of trading using opposite Oxford Nanopore and Crinetics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oxford Nanopore position performs unexpectedly, Crinetics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crinetics Pharmaceuticals will offset losses from the drop in Crinetics Pharmaceuticals' long position.| Oxford Nanopore vs. Lineage Cell Therapeutics | Oxford Nanopore vs. Cadrenal Therapeutics, Common | Oxford Nanopore vs. ImmuCell | Oxford Nanopore vs. Braxia Scientific Corp |
| Crinetics Pharmaceuticals vs. Viridian Therapeutics | Crinetics Pharmaceuticals vs. Cytokinetics | Crinetics Pharmaceuticals vs. Structure Therapeutics American | Crinetics Pharmaceuticals vs. Passage Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Global Correlations Find global opportunities by holding instruments from different markets |